‹ ›
MYP_069145
← PREVIOUS NEXT → BACK
Basic Information
HPV-31 L1 Cta
Antimicrobial
Antiviral
Antiviral ▸ Anti-HPV
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition ▸ Entry inhibitor
Enzyme modulation ▸ Enzyme inhibition ▸ Infection inhibition
Standard
13 amino acids
C69H115N25O15
Standard
Sequence
GYRARPKFKAGKR
Physicochemical Analysis
1534.81 Da
11.74
5.76
5.55
0.4428
-1.73
0.48
-0.64
11.49
15.38
0.1538
1490.00
1490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
687.72
-6.61
26.0
21.0
52.0
109.0
3.0
12.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0023085 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
inhibition of pseudovirions infection
91±4 %
Inhibition
PaperPubMed PMID: 15170645 PMID15170645 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/15170645/
RECORD: Rec_0087337 VERIFIED: YES
Provenance & Taxonomy
Human papillomavirus [Virus]
Virus-derived peptide
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor
Human papillomavirus (Virus entry); Cos-7
91 %
Luciferase assay
PaperPositively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity. | Bousarghin L, Touze A, Yvonnet B, Coursaget P. | J Med Virol. 2004 | PMID:15170645 PMID15170645 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/15170645/
RECORD: Rec_0189814 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
human papillomavirus
86±3 %
Inhibition
PaperPubMed PMID: 15170645 PMID15170645 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/15170645/
RECORD: Rec_0208006 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
PaperPubMed PMID: 15170645 PMID15170645 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/15170645/
RECORD: Rec_0237253 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HPV Entry inhibition
Human papillomavirus(HPV) | particle cell
6.515 μM
% inhibition
Mammalian: 30 h; Yeast: >20 h; E. coli: >10 h
PaperPositively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity. | Bousarghin L, Touzé A, Yvonnet B, Coursaget P. | J Med Virol. 2004 Jul;73(3):474-80. | DOI:10.1002/jmv.20114 | PMID:15170645 PMID15170645 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/15170645/
1 2 NEXT LAST
Showing 5 records on this page · Page 1 of 2